N-Methyl-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine, 98%, 100mg

Cubeta de muestra SpecTainer, 120 ml, Estéril, 300 Pieza(s)

2,3-Dimethyl-5-nitrobenzoic acid, 98%, 100mg

Dmf-dg, 95%, 25g

(3aR,8aS)-2-(Pyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 97%, 250mg

2-methylbut-2-enal, 95.0%, 25g

3-methyl 5-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-3,4-dihydropyridine-3,5-dicarboxylate, 99%, 5g

[2,2'-Bipyridine]-6-carboxylic acid, 95%, 1g

(S)-2-Amino-2-(3-bromophenyl)acetic acid, 95%, 250mg

4-Cyclopentene-1,3-dione, 97%, 250mg

Hexaconazole>95.0%(HPLC)(T)5g

3-Hydroxy-2-naphthoic Acid Hydrazide>98.0%(T)25g

2-Chloro-5-fluoro-3,8-dimethylquinoline, 95.0%, 500mg